Researchers presently investigating Opioid Growth Factor (OGF).
|
Researcher
|
Areas of Research
|
 |
Ian S. Zagon Ph.D.
Distinguished Professor, Distinguished Educator, and Director of the Program on Education in Human Structure
Hershey Medical Center, Penn State University College of Medicine
|
OGF as monotherapy or in combination with chemotherapy in various cancers, OGF for treating Multiple Sclerosis. Mechanism of Action of OGF in autoimmune diseases.
Learn more about Dr. Zagon >>
|
 |
Patricia J. McLaughlin Ph.D.
Professor of Neural and Behavioral Sciences and Director of the Graduate Program in Anatomy
Hershey Medical Center, Penn State University College of Medicine
|
OGF as monotherapy or in combination with chemotherapy in various cancers, OGF for treating Multiple Sclerosis. Mechanism of Action of OGF in autoimmune diseases.
Learn more about Dr. McLaughlin >>
|
 |
Jill P. Smith M.D.
Professor of Medicine
Hershey Medical Center, Penn State University College of Medicine
|
Clinical Trials of OGF as monotherapy or combined with Gemcitabine for treating Advanced Pancreatic Cancer.
Learn more about Dr. Smith >>
|
|
Moshe Rogosnitzky
Director of Research
MedInsight Research Institute
|
Stability of OGF in solution. Discovery of OGFr agonists.
Learn more about Moshe Rogosnitzky >>
|
 |
David Goldenberg M.D. FACS
Director of Head and Neck Surgery, Division of Otolaryngology-Head and Neck Surgery
Hershey Medical Center, Penn State University College of Medicine
|
OGF for treating patients with with Stage 4 head and neck cancer.
Learn more about Dr. Goldenberg >>
|